TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2011 DA - 2011// TI - Hallmarks of cancer: the next generation JO - Cell VL - 144 UR - https://doi.org/10.1016/j.cell.2011.02.013 DO - 10.1016/j.cell.2011.02.013 ID - Hanahan2011 ER - TY - JOUR AU - Stacker, S. A. AU - Williams, S. P. AU - Karnezis, T. AU - Shayan, R. AU - Fox, S. B. AU - Achen, M. G. PY - 2014 DA - 2014// TI - Lymphangiogenesis and lymphatic vessel remodelling in cancer JO - Nat Rev Cancer VL - 14 UR - https://doi.org/10.1038/nrc3677 DO - 10.1038/nrc3677 ID - Stacker2014 ER - TY - JOUR AU - Stacker, S. A. AU - Caesar, C. AU - Baldwin, M. E. AU - Thornton, G. E. AU - Williams, R. A. AU - Prevo, R. PY - 2001 DA - 2001// TI - VEGF-D promotes the metastatic spread of tumor cells via the lymphatics JO - Nat Med VL - 7 UR - https://doi.org/10.1038/84635 DO - 10.1038/84635 ID - Stacker2001 ER - TY - JOUR AU - Karaman, S. AU - Detmar, M. PY - 2014 DA - 2014// TI - Mechanisms of lymphatic metastasis JO - J Clin Invest VL - 124 UR - https://doi.org/10.1172/JCI71606 DO - 10.1172/JCI71606 ID - Karaman2014 ER - TY - JOUR AU - Cao, Y. PY - 2014 DA - 2014// TI - Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis JO - Nat Rev Cancer VL - 5 UR - https://doi.org/10.1038/nrc1693 DO - 10.1038/nrc1693 ID - Cao2014 ER - TY - JOUR AU - Alitalo, A. AU - Detmar, M. PY - 2014 DA - 2014// TI - Interaction of tumor cells and lymphatic vessels in cancer progression JO - Oncogene VL - 31 UR - https://doi.org/10.1038/onc.2011.602 DO - 10.1038/onc.2011.602 ID - Alitalo2014 ER - TY - JOUR AU - Baldwin, M. E. AU - Halford, M. M. AU - Roufail, S. AU - Williams, R. A. AU - Hibbs, M. L. AU - Grail, D. PY - 2005 DA - 2005// TI - Vascular endothelial growth factor D is dispensable for development of the lymphatic system JO - Mol Cell Biol VL - 25 UR - https://doi.org/10.1128/MCB.25.6.2441-2449.2005 DO - 10.1128/MCB.25.6.2441-2449.2005 ID - Baldwin2005 ER - TY - JOUR AU - Smith, N. R. AU - Baker, D. AU - James, N. H. AU - Ratcliffe, K. AU - Jenkins, M. AU - Ashton, S. E. PY - 2010 DA - 2010// TI - Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-2797 DO - 10.1158/1078-0432.CCR-09-2797 ID - Smith2010 ER - TY - JOUR AU - Achen, M. G. AU - Jeltsch, M. AU - Kukk, E. AU - Mäkinen, T. AU - Vitali, A. AU - Wilks, A. F. PY - 1998 DA - 1998// TI - Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) JO - Proc Natl Acad Sci U S A VL - 95 UR - https://doi.org/10.1073/pnas.95.2.548 DO - 10.1073/pnas.95.2.548 ID - Achen1998 ER - TY - JOUR AU - Karnezis, T. AU - Shayan, R. AU - Caesar, C. AU - Roufail, S. AU - Harris, N. C. AU - Ardipradja, K. PY - 2012 DA - 2012// TI - VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium JO - Cancer Cell VL - 14 UR - https://doi.org/10.1016/j.ccr.2011.12.026 DO - 10.1016/j.ccr.2011.12.026 ID - Karnezis2012 ER - TY - JOUR AU - Zhang, L. AU - Zhou, F. AU - Han, W. AU - Shen, B. AU - Luo, J. AU - Shibuya, M. PY - 2010 DA - 2010// TI - VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis JO - Cell Res VL - 20 UR - https://doi.org/10.1038/cr.2010.116 DO - 10.1038/cr.2010.116 ID - Zhang2010 ER - TY - JOUR AU - Skobe, M. AU - Hawighorst, T. AU - Jackson, D. G. AU - Prevo, R. AU - Janes, L. AU - Velasco, P. PY - 2007 DA - 2007// TI - Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis JO - Nat Med VL - 7 UR - https://doi.org/10.1038/84643 DO - 10.1038/84643 ID - Skobe2007 ER - TY - JOUR AU - Han, K. Y. AU - Chang, J. H. AU - Dugas-Ford, J. AU - Alexander, J. S. AU - Azar, D. T. PY - 2014 DA - 2014// TI - Involvement of lysosomal degradation in VEGF-C-induced down-regulation of VEGFR-3 JO - FEBS Lett VL - 588 UR - https://doi.org/10.1016/j.febslet.2014.09.034 DO - 10.1016/j.febslet.2014.09.034 ID - Han2014 ER - TY - JOUR AU - Nwogu, C. E. AU - Yendamuri, S. AU - Tan, W. AU - Kannisto, E. AU - Bogner, P. AU - Morrison, C. PY - 2013 DA - 2013// TI - Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction. correlation with vascular endothelial growth factor expression JO - J Thorac Cardiov Sur VL - 145 UR - https://doi.org/10.1016/j.jtcvs.2012.12.023 DO - 10.1016/j.jtcvs.2012.12.023 ID - Nwogu2013 ER - TY - JOUR AU - Hecht, J. R. AU - Trarbach, T. AU - Hainsworth, J. D. AU - Major, P. AU - Jäger, E. AU - Wolff, R. A. PY - 2011 DA - 2011// TI - Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.29.4496 DO - 10.1200/JCO.2010.29.4496 ID - Hecht2011 ER - TY - JOUR AU - Podar, K. AU - Anderson, K. C. PY - 2011 DA - 2011// TI - Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignancies JO - Curr Cancer Drug Targets VL - 11 UR - https://doi.org/10.2174/156800911798073113 DO - 10.2174/156800911798073113 ID - Podar2011 ER - TY - JOUR AU - Wilhelm, S. M. AU - Dumas, J. AU - Adnane, L. AU - Lynch, M. AU - Carter, C. A. AU - Schütz, G. PY - 2011 DA - 2011// TI - Regorafenib (BAY 73–4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity JO - Int J Cancer VL - 129 UR - https://doi.org/10.1002/ijc.25864 DO - 10.1002/ijc.25864 ID - Wilhelm2011 ER - TY - JOUR AU - Xu, Y. AU - Lin, H. AU - Meng, N. AU - Lu, W. AU - Li, G. AU - Han, Y. PY - 2013 DA - 2013// TI - YL529, a novel, orally available multikinase inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models JO - Brit J Pharmacol VL - 169 UR - https://doi.org/10.1111/bph.12216 DO - 10.1111/bph.12216 ID - Xu2013 ER - TY - JOUR AU - Shibuya, M. PY - 2011 DA - 2011// TI - Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies JO - Genes Cancer VL - 2 UR - https://doi.org/10.1177/1947601911423031 DO - 10.1177/1947601911423031 ID - Shibuya2011 ER - TY - JOUR AU - Jiang, Q. Q. AU - Fan, L. Y. AU - Yang, G. L. AU - Guo, W. H. AU - Hou, W. L. AU - Chen, L. J. PY - 2008 DA - 2008// TI - Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model JO - BMC cancer VL - 8 UR - https://doi.org/10.1186/1471-2407-8-242 DO - 10.1186/1471-2407-8-242 ID - Jiang2008 ER - TY - JOUR AU - Hu, J. AU - Ye, H. AU - Fu, A. AU - Chen, X. AU - Wang, Y. AU - Chen, X. PY - 2010 DA - 2010// TI - Deguelin–an inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor-D in lung tumor model JO - Int J Cancer VL - 127 UR - https://doi.org/10.1002/ijc.25253 DO - 10.1002/ijc.25253 ID - Hu2010 ER - TY - JOUR AU - Hirakawa, S. AU - Brown, L. F. AU - Kodama, S. AU - Paavonen, K. AU - Alitalo, K. AU - Detmar, M. PY - 2007 DA - 2007// TI - VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2006-05-021758 DO - 10.1182/blood-2006-05-021758 ID - Hirakawa2007 ER - TY - JOUR AU - Xu, Y. Z. AU - Zheng, R. L. AU - Zhou, Y. AU - Peng, F. AU - Lin, H. J. AU - Bu, Q. PY - 2011 DA - 2011// TI - Small molecular anticancer agent SKLB703 induces apoptosis in human hepatocellular carcinoma cells via the mitochondrial apoptotic pathway in vitro and inhibits tumor growth in vivo JO - Cancer Lett VL - 313 UR - https://doi.org/10.1016/j.canlet.2011.08.025 DO - 10.1016/j.canlet.2011.08.025 ID - Xu2011 ER - TY - JOUR AU - Liang, S. AU - Fu, A. AU - Zhang, Q. AU - Tang, M. AU - Zhou, J. AU - Wei, Y. PY - 2011 DA - 2011// TI - Honokiol inhibits HepG2 migration via down-regulation of IQGAP1 expression discovered by a quantitative pharmaceutical proteomic analysis JO - Proteomics VL - 10 UR - https://doi.org/10.1002/pmic.200900649 DO - 10.1002/pmic.200900649 ID - Liang2011 ER - TY - JOUR AU - Goldberg, L. AU - Kloog, Y. PY - 2006 DA - 2006// TI - A Ras Inhibitor Tilts the Balance between Rac and Rho and Blocks Phosphatidylinositol 3-KinaseaDependent Glioblastoma Cell Migration JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1878 DO - 10.1158/0008-5472.CAN-06-1878 ID - Goldberg2006 ER - TY - JOUR AU - Agarwal, A. AU - Covic, L. AU - Sevigny, L. M. AU - Kaneider, N. C. AU - Lazarides, K. AU - Azabdaftari, G. PY - 2008 DA - 2008// TI - Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer JO - Mol Cancer Ther VL - 7 UR - https://doi.org/10.1158/1535-7163.MCT-08-0177 DO - 10.1158/1535-7163.MCT-08-0177 ID - Agarwal2008 ER - TY - JOUR AU - Liu, J. Y. AU - Wei, Y. Q. AU - Yang, L. AU - Zhao, X. AU - Tian, L. AU - Hou, J. M. PY - 2003 DA - 2003// TI - Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2 JO - Blood VL - 102 UR - https://doi.org/10.1182/blood-2002-12-3772 DO - 10.1182/blood-2002-12-3772 ID - Liu2003 ER - TY - JOUR AU - Mikalsen, L. T. AU - Dhakal, H. P. AU - Bruland, O. S. AU - Nesland, J. M. AU - Olsen, D. R. PY - 2011 DA - 2011// TI - Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections JO - Anticancer Res VL - 31 ID - Mikalsen2011 ER - TY - JOUR AU - Petrovic, N. AU - Schacke, W. AU - Gahagan, J. R. AU - O’Conor, C. A. AU - Winnicka, B. AU - Conway, R. E. PY - 2007 DA - 2007// TI - CD13/APN regulates endothelial invasion and filopodia fonnation JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2006-02-002931 DO - 10.1182/blood-2006-02-002931 ID - Petrovic2007 ER - TY - JOUR AU - Hertel, J. AU - Hirche, C. AU - Wissmann, C. AU - Ebert, M. P. AU - Höcker, M. PY - 2014 DA - 2014// TI - Transcription of the vascular endothelial growth factor receptor-3 (VEGFR3) gene is regulated by the zinc finger proteins Sp1 and Sp3 and is under epigenetic control: transcription of vascular endothelial growth factor receptor 3 JO - Cell Oncol (Dordr) VL - 37 UR - https://doi.org/10.1007/s13402-014-0169-5 DO - 10.1007/s13402-014-0169-5 ID - Hertel2014 ER - TY - JOUR AU - Wen, J. AU - Fu, A. F. AU - Chen, L. J. AU - Xie, X. J. AU - Yang, G. L. AU - Chen, X. C. PY - 2009 DA - 2009// TI - Liposomal honokiol inhibits VEGF-D-induced lymphangiogenesis and metastasis in xenograft tumor model JO - Int J Cancer VL - 124 UR - https://doi.org/10.1002/ijc.24244 DO - 10.1002/ijc.24244 ID - Wen2009 ER - TY - JOUR AU - Yasuoka, H. AU - Nakamura, Y. AU - Zuo, H. AU - Tang, W. H. AU - Takamura, Y. AU - Miyauchi, A. PY - 2005 DA - 2005// TI - VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma JO - Modern pathol VL - 18 UR - https://doi.org/10.1038/modpathol.3800402 DO - 10.1038/modpathol.3800402 ID - Yasuoka2005 ER - TY - JOUR AU - Matsumoto, M. AU - Roufail, S. AU - Inder, R. AU - Caesar, C. AU - Karnezis, T. AU - Shayan, R. PY - 2013 DA - 2013// TI - Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis JO - Clin Exp Metastasis VL - 30 UR - https://doi.org/10.1007/s10585-013-9581-x DO - 10.1007/s10585-013-9581-x ID - Matsumoto2013 ER - TY - JOUR AU - Zhao, Y. C. AU - Ni, X. J. AU - Wang, M. H. AU - Zha, X. M. AU - Zhao, Y. AU - Wang, S. PY - 2012 DA - 2012// TI - Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients JO - Med Oncol VL - 29 UR - https://doi.org/10.1007/s12032-012-0205-0 DO - 10.1007/s12032-012-0205-0 ID - Zhao2012 ER - TY - JOUR AU - Cleaver, O. AU - Melton, D. A. PY - 2003 DA - 2003// TI - Endothelial signaling during development JO - Nat Med VL - 9 UR - https://doi.org/10.1038/nm0603-661 DO - 10.1038/nm0603-661 ID - Cleaver2003 ER - TY - JOUR AU - McCarty, M. AU - Wey, J. AU - Stoeltzing, O. AU - Liu, W. AU - Fan, F. AU - Bucana, C. PY - 2004 DA - 2004// TI - ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor with additional activity against epidermal growth factor receptor tyrosine kinase, inhibits orthotopic growth and angiogenesis of gastric cancer JO - Mol Cancer Ther VL - 3 ID - McCarty2004 ER - TY - JOUR AU - Gaengel, K. AU - Genove, G. AU - Armulik, A. AU - Betsholtz, C. PY - 2009 DA - 2009// TI - Endothelial-mural cell signaling in vascular development and angiogenesis JO - Arterioscl Throm Vas Biol VL - 29 UR - https://doi.org/10.1161/ATVBAHA.107.161521 DO - 10.1161/ATVBAHA.107.161521 ID - Gaengel2009 ER - TY - JOUR AU - Debinski, W. AU - Slagle-Webb, B. AU - Achen, M. G. AU - Stacker, S. A. AU - Tulchinsky, E. AU - Gillespie, G. Y. PY - 2001 DA - 2001// TI - VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme JO - Mol Med VL - 7 ID - Debinski2001 ER -